Profil
Patrick Loustau formerly worked at Bristol Myers Squibb Co., as Senior Vice President-Global Commercialization in 2014, Novo Nordisk A, as Senior VP-Global Marketing & Medical Affairs in 2010, and Zafgen, Inc., as President from 2014 to 2016.
Mr. Loustau received his graduate degree from Université de Paris XI Paris Sud.
Anciens postes connus de Patrick Loustau
| Sociétés | Poste | Fin |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | President | 19/07/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/04/2014 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/2010 |
Formation de Patrick Loustau
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Entreprise privées | 2 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
| Université de Paris XI Paris Sud | Consumer Services |